Medical Technology

Abstract

This Program Element (PE) supports application of knowledge gained through basic research to refine drugs, vaccines, medical devices, diagnostics, medical practices/ procedures, and other preventive measures essential to the protection and sustainment of Warfighter health. Research is conducted in five principal areas: Combat Casualty Care, Military Operational Medicine, Military Relevant Infectious Diseases, Clinical and Rehabilitative Medicine, Medical Capabilities to Support Dispersed Operations, and Systems Biology/Network Sciences. Projects are coordinated with the Defense Health Agency. The cited research is consistent with the Under Secretary of Defense for Research and Engineering science and technology focus areas and the Army Modernization Strategy. Work in this Program element (PE) is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD. All medical applied research is conducted in compliance with Food and Drug Administration (FDA) or Environmental Protection Agency (EPA) regulations. The FDA requires thorough testing in animals (preclinical testing) to ensure safety and, where possible, effectiveness prior to evaluation in controlled human clinical trials (upon transition to Advanced Technology Development). This PE focuses on research and refinement of technologies such as product formulation and purification and laboratory test refinement with the aim of identifying candidate solutions. This work often involves testing in animal models. The EPA also requires thorough testing of products, such as sterilants, disinfectants, repellents, and insecticides to ensure the environment is adequately protected before these products are licensed for use. Program refinement and execution is externally peer-reviewed and fully coordinated with all Services as well as other agencies through the Joint Technology Coordinating Groups of the Armed Services Biomedical Research Evaluation and Management (ASBREM) Community of Interest (COI). The ASBREM COI, formed under the authority of the Assistant Secretary of Defense for Research and Engineering, serves to facilitate coordination and prevent unnecessary duplication of effort within the Department of Defenses (DoD) biomedical research community, as well as their associated enabling research areas.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2023
Source ID
0602787A_2_2040_PB_2023
Change Summary Explanation
Fiscal Year 2023 (FY23) funding increase reflects the fact that the FY22 President's Budget request did not include out-year funding.
Service Agency Name
Army

Entities

Organizations

  • United States Army

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Combat Casualty Care
  • Combat Injuries
  • Debridement
  • Health Services
  • Injury Prevention
  • Medical Evacuation
  • Medical Personnel
  • Military Medicine
  • Test And Evaluation
  • Unmanned Aerial Systems
  • Unmanned Aerial Vehicles
  • Unmanned Systems
  • Wounds And Injuries

Readers

  • Infectious Disease/Epidemiology
  • Medical or Health Care Field.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents